Difficulty: Medium
Average Score: 80%
Practice
Initial therapy for most patients with type 2 diabetes should begin with:
Correct answer
B
Rationale
Metformin is initial therapy for type 2 diabetes (ADA) it reduces hepatic glucose output, dropping A1C 1-2% (e.g., 90% efficacy, NEJM) with low hypoglycemia risk. Sulfonylureas increase insulin secretion second-line due to hypoglycemia (5-10%). Insulin is later costly, invasive. Thiazolidinediones (e.g., pioglitazone) risk fluid retention. Metformin's safety/efficacy, per guidelines, makes B the choice.